Monkeypox: The New Pandemic of 2022




Monkeypox; Virus; Disease.


This literature review addresses monkeypox, an infectious disease caused by the Monkeypox virus that belongs to the genus Orthopoxvirus and to the family Poxviridae, the same as the human smallpox virus. It had its first case registered in Congo in 1970. After almost 40 years, with no reported case, in 2017 it re-emerged in Nigeria. With the absence of mass vaccination and its transmission occurring through direct contact with people infected through close and prolonged exposure to droplets or other respiratory secretions, this virus has already originated in more than 44 countries, causing a new global pandemic. With a low mortality rate, which can reach between 3% and 6%, its symptoms are very similar to those observed in patients with smallpox, although they are clinically less severe. Thus, the present work aimed to study the characteristics and general aspects of monkeypox, in order to take measures to prevent and promote this disease.


ANVISA – Agência Nacional de Vigilância Sanitária. Orientações para Prevenção e Controle. [s.l: s.n.]. (2022). <>.

Brasil, M. DA S. Agentes Biológicos Classificação de Risco dos Agentes Biológicos. [s.l: s.n.]. 2017. < df>.

Breman, J. G., Kalisa-Ruti, Steniowski, M. V., Zanotto, E., Gromyko, A. I., & Arita, I. (1980). Human monkeypox, 1970-79. Bulletin of the World Health Organization, 58(2), 165–182.

Catalent Pharma Solutions (2018, July). HIGHLIGHTS OF PRESCRIBING INFORMATION: These highlights do not include all the information needed to use TPOXX® safely and effectively. See full prescribing information for TPOXX.

CDC. (2022, October 26). Monkeypox in the U.S. Centers for Disease Control and Prevention.

Monkeypox infections in animals: updated interim guidance for persons who have frequent contact with animals (pet owners, pet shop owners and employees, animal rescuers, animal handlers, and animal control officers). (n.d.).

CDC. (2022, October 19). Monkeypox in the U.S. Centers for Disease Control and Prevention.

ECDC – EUROPEAN CENTRE FOR DISEASE PREVNETION AND CONTROL. Interim advice on Risk Communication and Community Engagement during the monkeypox outbreak in Europe, 2022 Situation analysis Monkeypox outbreak in Europe Risk communication response. 2022. Acesso em 10/06/2022. [s.l: s.n.]. Disponível em: < advice-on-RCCE-for-Monkeypox-2-June-2022.pdf>.

European Centre for Disease Prevention and Control (ECDC). Hepatitis A outbreaks in the EU/EEA mostly affecting men who have sex with men [Internet]. 2017[cited 2022 Jun 20]. Publications/16-02-2017-RRA%20UPDATE%201-Hepatitis%20A-United%20Kingdom.pdf

Guarner, J., Johnson, B. J., Paddock, C. D., Shieh, W.-J., Goldsmith, C. S., Reynolds, M. G., Damon, I. K., Regnery, R. L., & Zaki, S. R. (2004). Monkeypox Transmission and Pathogenesis in Prairie Dogs. Emerging Infectious Diseases, 10(3), 426–431.

Lopera, J. G., Falendysz, E. A., Rocke, T. E., & Osorio, J. E. (2015). Attenuation of monkeypox virus by deletion of genomic regions. Virology, 475, 129–138.

McCollum, A. M., Reynolds, M. G., Ndongala, G. M., Pukuta, E., Tamfum, J.-J. M., Malekani, J., Karhemere, S., Lushima, R. S., Wilkins, K., Gao, J., Emerson, G., Damon, I. K., Li, Y., Ilunga, B. K., Kabamba, J., Carroll, D. S., & Nakazawa, Y. (2015). Human Monkeypox in the Kivus, a Conflict Region of the Democratic Republic of the Congo. The American Journal of Tropical Medicine and Hygiene, 93(4), 718–721.

Minhaj, F. S. (2022). Monkeypox Outbreak — Nine States, May 2022. MMWR. Morbidity and Mortality Weekly Report, 71.

Monkeypox Outbreak Toolbox. (n. d.).

Parker, S., Chen, N. G., Foster, S., Hartzler, H., Hembrador, E., Hruby, D., Jordan, R., Lanier, R., Painter, G., Painter, W., Sagartz, J. E., Schriewer, J., & Mark Buller, R. (2012). Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox. Antiviral Research, 94(1), 44–53.

Pinkstone J. Grindr sends monkeypox warnings to users as cases rise [Internet]. 2022[cited 2022 Jun 20]. The Telegraphy.

SMS-SP – SECRETARIA MUNICIPAL DE SAÚDE DE SÃO PAULO. Capital confirma primeiro caso de monkeypox no Brasil (2022). Disponível em:<>.

Sousa AR, Cerqueira SSB, Santana TS, Suto CSS, Almeida ES, Brito LS, et al. Estigma vivenciado por homens diagnosticados com COVID-19. Rev Bras Enferm. 2022;75(Suppl 1):e20210038.

UNAIDS. Press Release: UNAIDS warns that stigmatizing language on Monkeypox jeopardises public health [Internet]. 2022[cited 2022 Jun 20] may/20220522_PR_Monkeypox

Weinstein, R. A., Nalca, A., Rimoin, A. W., Bavari, S., & Whitehouse, C. A. (2005). Reemergence of Monkeypox: Prevalence, Diagnostics, and Countermeasures. Clinical Infectious Diseases, 41(12), 1765–1771.

Whitemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of Advanced Nursing, 52(5), 546–553.

WHO press conference on COVID-19, monkeypox and other global health issues - 5 October 2022. (n.d.).

World Health Organization (21 May 2022). Disease Outbreak News; Multi-country monkeypox outbreak in non-endemic countries.

World Health Organization (WHO). Laboratory testing for the monkeypox virus: interim guidance. Geneva: WHO; 23 maio 2022 [citado em 27 set. 2022].

World Health Organization (WHO). Surveillance, case investigation and contact tracing for monkeypox: interim guidance. Geneva, 25 ago. 2022 [citado em 27 set. 2022].




How to Cite

SOUZA, A. A. de .; ALBUQUERQUE, G. B. de .; DANTAS, L. K. M. de A. .; DUARTE, M. G. .; MORAES, L. M. B. de .; SILVA, L. B. .; CUNHA, R. S. C. . Monkeypox: The New Pandemic of 2022. Research, Society and Development, [S. l.], v. 12, n. 2, p. e28112238461, 2023. DOI: 10.33448/rsd-v12i2.38461. Disponível em: Acesso em: 7 jun. 2023.



Health Sciences